{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/streamlining-literature-surveillance-process-improve-market-value-communications#webpage",
"url": "https://www.fortrea.com/insights/streamlining-literature-surveillance-process-improve-market-value-communications",
"name": "Streamlining the literature surveillance process to improve market value communications",
"description": "This Fortrea case study explores how literature surveillance processes were streamlined to support pharmacovigilance reporting and regulatory compliance activities across safety operations. The study involved a pharmaceutical company seeking to improve literature surveillance workflows related to individual case safety reports (ICSRs), aggregate reporting, signal detection activities, and ongoing pharmacovigilance management. The case study highlights challenges related to inconsistent literature review workflows, operational inefficiencies, reporting process gaps, and alignment with global pharmacovigilance regulatory requirements. Fortrea conducted workflow assessments, process mapping, gap analysis, and literature surveillance optimization activities to improve consistency across pharmacovigilance operations and support regulatory reporting requirements. By integrating literature surveillance process improvements with structured pharmacovigilance operational support and safety reporting workflows, the approach strengthened reporting efficiency, process standardization, and regulatory compliance management across literature surveillance activities."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Streamlining the literature surveillance process to improve market value communications",
"item": "https://www.fortrea.com/insights/streamlining-literature-surveillance-process-improve-market-value-communications"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/streamlining-literature-surveillance-process-improve-market-value-communications#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/streamlining-literature-surveillance-process-improve-market-value-communications#webpage"
},
"headline": "Streamlining Literature Surveillance Processes for Pharmacovigilance Reporting | Fortrea Case Study",
"description": "This Fortrea case study explores how literature surveillance processes were streamlined to support pharmacovigilance reporting and regulatory compliance activities across safety operations. The study involved a pharmaceutical company seeking to improve literature surveillance workflows related to individual case safety reports (ICSRs), aggregate reporting, signal detection activities, and ongoing pharmacovigilance management. The case study highlights challenges related to inconsistent literature review workflows, operational inefficiencies, reporting process gaps, and alignment with global pharmacovigilance regulatory requirements. Fortrea conducted workflow assessments, process mapping, gap analysis, and literature surveillance optimization activities to improve consistency across pharmacovigilance operations and support regulatory reporting requirements. By integrating literature surveillance process improvements with structured pharmacovigilance operational support and safety reporting workflows, the approach strengthened reporting efficiency, process standardization, and regulatory compliance management across literature surveillance activities.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/streamlining-the-literature-surveillance-process.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/streamlining-the-literature-surveillance-process.pdf",
"encodingFormat": "application/pdf"
}
}
]
}